CX3CR1 and ST Elevation Myocardial Infarction: Our group has shown that T-lymphocytes contribute to myocardial ischaemia/reperfusion injury after primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI), with the fractalkine receptor, CX3CR1, playing a central role (5).